Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke.
NCT03812666 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-11-18
Summary
This study will look for new biomarkers of infection and evaluate current biomarkers of infection in stroke patients. Patients with acute stroke will be monitored with daily blood samples for seven days and by clinical examination to detect infections for 10 days.
Conditions
- Stroke, Acute
- Pneumonia, Bacterial
Sponsors & Collaborators
-
Örebro University, Sweden
collaborator OTHER -
Jakob Ström
lead OTHER
Principal Investigators
-
Jakob Ström, MD, PhD · Region Örebro County
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-15
- Primary Completion
- 2023-07-01
- Completion
- 2025-07-01
Countries
- Sweden
Study Locations
More Related Trials
-
Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke
NCT05799326 ·Status: RECRUITING ·Phase: NA
-
Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy
NCT02900833 ·Status: ACTIVE_NOT_RECRUITING
-
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke
NCT03618290 ·Status: COMPLETED
-
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
NCT02961348 ·Status: COMPLETED ·Phase: NA
-
Activated Protein C in Acute Stroke Trial
NCT00533546 ·Status: TERMINATED ·Phase: PHASE2
-
Neuroprotection in Acute Ischemic Stroke
NCT03320018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase Ib/II in Patients With Acute Ischemic Stroke
NCT02963376 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
NCT01092819 ·Status: COMPLETED
-
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
NCT07121569 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation
NCT02753257 ·Status: UNKNOWN
-
Atherogenic Lipoproteins in Ischemic Stroke
NCT05090878 ·Status: RECRUITING
-
The Role of Hyperoxia in Acute Ischemic Stroke
NCT03904017 ·Status: TERMINATED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Inflammatory Biomarkers as Tool in Diagnosis and Management of Patients With Ischemic Stroke
NCT01787877 ·Status: UNKNOWN
-
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
NCT03463551 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Procoagulation Markers in Stroke Patients
NCT01811550 ·Status: COMPLETED
-
Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)
NCT00795288 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
NCT00119626 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
NCT03772457 ·Status: UNKNOWN
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization
NCT02533778 ·Status: SUSPENDED ·Phase: NA
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
NCT00238667 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2